TEPEZZA

Formula & Concentration

TEPEZZA (teprotumumab-trbw) for injection, for intravenous use

Manufacturer

Horizon Therapeutics

Indications

TEPEZZA is an insulin-like growth factor-1 receptor inhibitor indicated for the treatment of Thyroid Eye Disease

Product Options

Package Size

NDC #

Presentation

500 mg

75987-0130-15

Vial

Shelf Life and Storage

Refrigerate at 2°C to 8°C (36°F to 46°F) in original carton until time of use to protect from light. Do not freeze.